WallStreetZenWallStreetZen

NASDAQ: SCNI
Scinai Immunotherapeutics Ltd Earnings Dates, Reports, Calls

OverviewEarnings
RevenueDividendOwnership
Scinai Immunotherapeutics earnings were -$4.4M for the trailing 12 months ending Jun 30, 2025, with -50% growth year over year. The latest SCNI earnings report on Jun 30, 2025 announced Q2 2025 earnings of N/A, down N/A from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, SCNI reported annual earnings of -$4.8M, with -173.8% growth.

SCNI past earnings growth

How has SCNI's earnings growth performed historically?

Company
-50%
Industry
30.11%
Market
34.43%
SCNI's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
SCNI's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance

SCNI earnings history

Current Revenue
$1.1M
Current Earnings
-$4.4M
Current Profit Margin
-387.9%

SCNI Return on Equity

Current Company
-1,550.2%
Current Industry
-10%
Current Market
30.7%
SCNI's Return on Equity (-1,550.2%)... subscribe to Premium to read more.
High Return on Equity Performance

SCNI undefined

Current Company
-33.3%
Current Industry
-0.2%
SCNI is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when SCNI announces earnings.

SCNI undefined

Current Company
-59.4%
Current Industry
6.4%
SCNI's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

SCNI vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
SCNI-$4.07M-$4.45M-45.45%$4.00
BDRX-$35.88M-$33.34MN/A-$891,150.27
NCNA-$27.40M-$42.91MN/A-$202.70
PLRZ-$1.18M-$1.55MN/A-$125.00
REVB-$14.38M-$14.41MN/A-$201.69
View Top Biotech Stocks

Scinai Immunotherapeutics Earnings Reports & History FAQ

What were Scinai Immunotherapeutics's earnings last quarter?

Scinai Immunotherapeutics (NASDAQ: SCNI) reported Q2 2025 earnings per share (EPS) of N/A, up N/A year over year. Total SCNI earnings for the quarter were N/A. In the same quarter last year, Scinai Immunotherapeutics's earnings per share (EPS) was -$4.00.

If you're new to stock investing, here's how to buy Scinai Immunotherapeutics stock.

Is Scinai Immunotherapeutics profitable or losing money?

As of the last Scinai Immunotherapeutics earnings report, Scinai Immunotherapeutics is currently losing money. Scinai Immunotherapeutics's net profit (also called net income) for the twelve months ending Jun 30, 2025 was -$4.45 million, a 244.35% decrease year over year.

What was SCNI's earnings growth in the past year?

As of Scinai Immunotherapeutics's earnings date in Q3 2025, Scinai Immunotherapeutics's earnings has grown -50% year over year. This is 80.11 percentage points lower than the US Biotechnology industry earnings growth rate of 30.11%. SCNI earnings in the past year totalled -$4.45 million.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.